Bladder cancer Board decisions

The Veteran's claims for service connection for Parkinson's Disease and Bladder cancer are remanded due to incomplete medical opinions regarding the onset and etiology of these conditions. The Board finds that there is insufficient evidence to support a finding of herbicide exposure, thus precluding application of presumptive provisions.

The Board has decided to remand the claim of service connection for bladder cancer due to a duty to assist error and requires an adequate opinion regarding the etiology of the Veteran's condition.

The Board has granted compensation for residuals of bladder cancer, iron deficiency anemia, chronic kidney disease, gastrointestinal disorders, and hypertension as qualifying additional disabilities under 38 U.S.C. § 1151 due to VA's failure to timely diagnose and treat the Veteran's conditions.

The Veteran's appeal was dismissed because the appellant, who is now deceased, had no pending claims affected by the 2021 amendments to 38 U.S.C. 1116 regarding presumptive service connection based on herbicide exposure.

The Board has restored the Veteran's disability rating for bladder cancer from noncompensable to 100% effective August 1, 2009. The reduction was not proper as there was no evidence of improvement in the Veteran's ability to function under ordinary conditions.

The Veteran's bladder cancer is remanded for further examination and opinion to address the nature and etiology of his condition, including in-service exposure to toxic chemicals.

The Board has previously granted service connection for bladder cancer and cause of death, with the highest schedular rating available. The appeal is dismissed as moot.

The Veteran's claim for service connection for sleep apnea is dismissed as the Veteran withdrew his appeal.,Service connection for bladder cancer and hypertension are granted due to in-service exposure to herbicide agents. The Veteran has current diagnoses of these conditions.

The Board denied the Veteran's claims for service connection for bladder cancer, coronary artery disease (claimed as ischemic heart disease), and diabetes mellitus type II due to a lack of evidence linking these conditions to his military service or exposure to herbicide agents.

The Veteran's claim for an earlier effective date for service connection of bladder cancer was denied as there is no evidence of a formal or informal claim prior to August 11, 2023. The medical records did not suggest the existence of bladder cancer until after this date.

The Veteran's service connection claim for residuals of bladder cancer is granted, as the evidence supports a diagnosis of bladder cancer and its association with herbicide agent exposure.

The Veteran's claim for an earlier effective date for service connection of bladder cancer was denied as there is no evidence of a formal or informal claim prior to August 11, 2023. The medical records did not suggest the existence of bladder cancer until after this date.

The Veteran's claims for service connection for coronary artery disease, hypertension, prostate cancer, and bladder cancer are being remanded due to the need for additional medical opinions regarding his exposure to jet fuel exhaust and herbicide agents during service.

The Board has granted the Veteran's claim for service connection for a persistent depressive disorder, finding that it is secondary to his service-connected prostate and bladder cancer.

The Board has granted service connection for erectile dysfunction as secondary to the Veteran's inactive bladder cancer, finding that there is an approximate balance of positive and negative evidence supporting this claim.

The Veteran's appeal for an earlier effective date for service connection of bladder cancer was dismissed due to the Veteran's death.

The Veteran's service connection for bladder cancer and associated lymph node cancer was granted effective June 28, 2013.

The Board has remanded the Veteran's claims for service connection due to his exposure to carbon tetrachloride and ionizing radiation during service. Additional development is needed, including obtaining medical opinions on whether these exposures caused or contributed to the Veteran's claimed conditions.

The Veteran's claim for a higher rating for bladder cancer is remanded due to the lack of a kidney examination, which could affect the current severity assessment.

The Veteran's bladder cancer is rated as 100 percent prior to March 20, 2023, and in excess of 40 percent since. The Board has remanded the case for further development to clarify if there has been any recurrence or metastasis of the Veteran's bladder cancer.